RxDoctor Payments Data

Robert Wood

Pediatric Allergy/Immunology · Baltimore, MDNPI 1508894221

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,073 of the $17,218 with a category attached, or 99.2%. Genentech USA, Inc. accounts for 81.0% of it on its own, with 1 other manufacturer making up the rest. 2024 is the largest year on record at $7,200, 2.2 times the $3,273 reported in 2021.

$17,218in general payments, 2019–2025

Across 4 payments — averaging $4304.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$14K
  • Regeneron$3K
$19,001,147in research payments, 2019–2025

Across 90 payments — averaging $211,124 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$17.8M
  • Novartis$644K
  • Regeneron$270K
  • Aimmune Therapeutics, Inc.$239K
  • Sanofi US Services Inc.$10K
  • Novartis Pharma AG$43

What the payments were for

  • Consulting fees$17,07399%
  • Travel & lodging$1461%

General payments by program year

21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.3$13,946
Regeneron1$3,273

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in Marylandto place this figure against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →